Characteristics and outcome of COVID-19 in patients with relapsing multiple sclerosis receiving Ofatumumab

Authors
Category Primary study
JournalNeurology
Year 2021
This article has no abstract
Epistemonikos ID: 44cc0cfd3210b9967ecd14a5cef987b1a99048a0
First added on: Feb 13, 2025